PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $79,000 | -20.2% | 34,000 | 0.0% | 0.03% | -22.2% |
| Q1 2018 | $99,000 | +10.0% | 34,000 | +3.0% | 0.04% | +9.1% |
| Q4 2017 | $90,000 | -18.9% | 33,000 | 0.0% | 0.03% | -21.4% |
| Q3 2017 | $111,000 | +50.0% | 33,000 | +10.0% | 0.04% | +50.0% |
| Q2 2017 | $74,000 | +8.8% | 30,000 | 0.0% | 0.03% | +12.0% |
| Q1 2017 | $68,000 | +7.9% | 30,000 | 0.0% | 0.02% | +8.7% |
| Q4 2016 | $63,000 | -37.0% | 30,000 | 0.0% | 0.02% | -37.8% |
| Q3 2016 | $100,000 | +6.4% | 30,000 | 0.0% | 0.04% | +2.8% |
| Q2 2016 | $94,000 | -5.1% | 30,000 | 0.0% | 0.04% | -7.7% |
| Q1 2016 | $99,000 | +7.6% | 30,000 | +15.4% | 0.04% | +5.4% |
| Q4 2015 | $92,000 | -16.4% | 26,000 | +18.2% | 0.04% | -19.6% |
| Q3 2015 | $110,000 | +14.6% | 22,000 | +46.7% | 0.05% | +31.4% |
| Q2 2015 | $96,000 | -2.0% | 15,000 | +7.1% | 0.04% | 0.0% |
| Q1 2015 | $98,000 | – | 14,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |